391
Views
19
CrossRef citations to date
0
Altmetric
Retina

Effects of Intravitreal Ranibizumab in the Treatment of Retinopathy of Prematurity in Chinese Infants

, , , , , & show all
Pages 1092-1097 | Received 08 Jun 2015, Accepted 12 Aug 2015, Published online: 18 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chen Jiang, Lu Ruan, Juan Zhang & Xin Huang. (2018) Inhibitory Effects On Retinal Neovascularization by Ranibizumab and sTie2-Fc in An Oxygen-Induced Retinopathy Mouse Model. Current Eye Research 43:9, pages 1190-1198.
Read now
Murat Gunay, Emine Alyamac Sukgen, Gokhan Celik & Yusuf Kocluk. (2017) Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey. Current Eye Research 42:3, pages 462-469.
Read now

Articles from other publishers (17)

Nimesh A. Patel, Luis A. Acaba-Berrocal, Sandra Hoyek, Kenneth C. Fan, Maria Ana Martinez-Castellanos, Caroline R. Baumal, C. Armitage HarperIIIIII, Audina M. Berrocal, Wu Wei-Chi, Rand Spencer, Shunji Kusaka, Polly Quiram, Jose Asilis, Michael P. Blair, Swati Agarwal, Anna Ells, Cagri G. Besirli, Irena Tsui, Thomas C. Lee, Aaron Nagiel, Andrés Kychenthal, Jessica Kovarik, Anton Orlin, Janet Alexander, Vaidehi S. Dedania, Sengul Ozdek, Michel J. Shami, Cornelius Regan, Shilpa Desai, Moran Roni Levin, Deborah Y. Chong, Mrinali Gupta, Adam Pflugrath, Ashkan Abbey, Christopher G. Fuller, Lori E. Coors, Nicolas Yannuzzi, Catherine Negron, Hasenin Al-khersan, Paul Runge, Huseyin Baran Ozdemir, Tugce Kucukbalci, Chiharu Iwahashi, Mark Solinski, David Sutter, Jonathan Sears, Christine Sonnie, David Portney, Jake Duker, Tamara Lenis, Andreas Di-Luciano, Pablo Chamartin, Nikisha Kothari, Grecia Yael Ortiz-Ramirez, Gabriela Patricia Amadeo Oreggioni, Ameay V. Naravane, Peter J. Belin, Nahomy Ledesma Vicioso, Demetrios Vavvas, M. Elizabeth Hartnett, Robinson V.P. Chan, Eric Nudleman, Darius M. Moshfeghi, Atchara Amphornphruet, Michael Chiang & Michael J. Shapiro. (2022) Practice Patterns and Outcomes of Intravitreal Anti-VEGF Injection for Retinopathy of Prematurity. Ophthalmology 129:12, pages 1380-1388.
Crossref
Rania M. Bassiouny, Walid M. Gaafar, Amgad El Nokrashy, Ameera G. Abdelhameed, Eman A. Attallah, Ahmed G. Elgharieb & Mohamed R. Bassiouny. (2021) Clinical outcome following reinjection of Ranibizumab for reactivation of retinopathy of prematurity. Eye 36:11, pages 2137-2143.
Crossref
Zhenquan Wu, Jinfeng Zhao, Waiching Lam, Mingmin Yang, Lu Chen, Xuelin Huang, Meirong Wei, Hui Yang, Fan Lv, Fuyan Zhang, Jian Zeng & Guo-Ming Zhang. (2022) Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial. British Journal of Ophthalmology 106:7, pages 975-979.
Crossref
Elçin Süren, Dilek Özkaya, Ersan Çetinkaya, Mustafa Kalaycı, Kenan Yiğit, Mehmet Fatih Kücük & Muhammet Kazim Erol. (2022) Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment. International Ophthalmology 42:6, pages 1905-1913.
Crossref
Andrew SH. Tsai, Hung-Da Chou, Xiao Chun Ling, Tala Al-Khaled, Nita Valikodath, Emily Cole, Vivien L. Yap, Michael F. Chiang, R.V. Paul Chan & Wei-Chi Wu. (2022) Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Progress in Retinal and Eye Research 88, pages 101018.
Crossref
Chiharu Iwahashi, Shoko Utamura, Kazuki Kuniyoshi, Koji Sugioka, Yuhei KonishiNorihisa WadaShunji Kusaka. (2021) FACTORS ASSOCIATED WITH REACTIVATION AFTER INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB THERAPY IN INFANTS WITH RETINOPATHY OF PREMATURITY. Retina 41:11, pages 2261-2268.
Crossref
SwapnilM Parchand, Deepanshu Agrawal, Anil Gangwe, Tripti Saraogi & Deepshikha Agrawal. (2021) Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity. Indian Journal of Ophthalmology 69:8, pages 2164.
Crossref
Kiet-Phang LingPei-Ju Liao, Nan-Kai WangAn-Ning ChaoKuan-Jen ChenTun-Lu ChenYih-Shiou HwangChi-Chun LaiWei-Chi Wu. (2020) RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY. Retina 40:9, pages 1793-1803.
Crossref
Xu Wang, Ke Shen, Fang Lu & Shigang He. (2018) Long-lasting impairments in rodent oxygen-induced retinopathy measured by retinal vessel density and visual function. Science China Life Sciences 62:5, pages 681-690.
Crossref
Jianting Liu, Xiaogang Wang, Jinfeng Wang & Haike Guo. (2019) Optical Quality and Intraocular Scattering in the Diabetic Eye without Diabetic Retinopathy. Optometry and Vision Science 96:4, pages 248-255.
Crossref
Emine Alyamaç Sukgen & Yusuf Koçluk. (2018) Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity. Graefe's Archive for Clinical and Experimental Ophthalmology 257:1, pages 49-55.
Crossref
Zijing Li, Yichi Zhang, Yunru Liao, Rui Zeng, Peng Zeng & Yuqing Lan. (2018) Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP). BMC Ophthalmology 18:1.
Crossref
Irena Tsui & Alison Chu. (2017) Hot Topics in Retinopathy of Prematurity. Pediatric Annals 46:11.
Crossref
. (2017) Anti-VEGF for ROP and Pediatric Retinal Diseases. Asia-Pacific Journal of Ophthalmology.
Crossref
David K. Wallace. (2016) Retinopathy of Prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus 20:6, pages 476-478.
Crossref
Jinali R. Patel, Sinthu S. Ranjan & Barry N. Wasserman. (2016) Antivascular endothelial growth factor in the treatment of retinopathy of prematurity. Current Opinion in Ophthalmology 27:5, pages 387-392.
Crossref
Yu Xu, Xiaoli Kang, Qi Zhang, Qiujing Huang, Jiao Lv & Peiquan Zhao. (2016) Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage. Journal of Ophthalmology 2016, pages 1-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.